COLL vs INTC · P/E 17, rev $181.9M vs rev $52.85B
Collegium Pharmaceutical Inc (COLL) versus Intel Corporation (INTC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported INTC revenue for 2025-12-27 was $52.85B. Net income was -$267.0M. Revenue was down 0.5% from 2024-12-28 to 2025-12-27. INTC currently screens at market cap $498.43B.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. INTC currently screens at market cap $498.43B.
Not investment advice. Open the COLL and INTC stock pages for the full models.
Not investment advice.